Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    LY2940680 | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting A Phase 1B/2 Study of LY2940680 in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Condition: Esophageal Cancer
Interventions: Drug: LY2940680;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiation Therapy;   Procedure: Endoscopy
2 Not yet recruiting A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Conditions: Solid Tumor;   Breast Cancer;   Colon Cancer;   Cholangiocarcinoma;   Soft Tissue Sarcoma
Interventions: Drug: LY3039478;   Drug: Taladegib;   Drug: Abemaciclib;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: LY3023414

Indicates status has not been verified in more than two years